Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
Fred Hutchinson Cancer Center (Fred Hutch and the University of Washington (UW) Department of Pediatrics, Division of Hematology Oncology are jointly recruiting a full-time advanced Pediatric Bone Marrow Transplant/Immunotherapy Fellow (Research Associate) with an appointment as Acting Instructor in the Department of Pediatrics at the University of Washington School of Medicine. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in pediatric hematopoietic cell transplantation (HCT) and Immunotherapy. This position will rotate through outpatient HCT services (autologous and allogeneic transplant, immunotherapy, long term follow up/survivorship) and on the inpatient transplant service with increasing levels of independent patient care responsibility over the course of the year. Exposure to some of our unique clinical programs (including non-malignant transplantation, high risk leukemia, and survivorship) will be part of the learning experience as well. Approximately 75% of the year will be devoted to clinical activities with the remaining time available for the opportunity to participate in research projects, which will be determined based on identification of mentors and projects. University of Washington faculty engage in teaching, research, and service.
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
Application Instructions:
The annual base salary range for this position is from $130,000 to $164,986, and pay offered will be based on experience and qualifications.
This position may be eligible for relocation assistance.
Although Fred Hutch is not sponsoring most H-1B visas at this time, candidates who already hold an H-1B sponsored by another organization and are currently in the U.S. may be eligible for this position.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (22 days per year), paid sick leave (up to 30 calendar days per occurrence of a qualifying reason), paid holidays (up to 13 days per year), and paid parental leave (up to 4 weeks).
This position is paid directly by Fred Hutchinson Cancer Center and receives no UW compensation.
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide.
An independent, nonprofit organization, Fred Hutch also serves as UW Medicine’s cancer program. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Fred Hutchinson Cancer Center will accelerate the development, evaluation, and use of new cancer discoveries and treatments and will offer patients greater access to clinical trials, bringing research and clinical care closer together. For current patients the superior care you have come to expect from us will continue uninterrupted. For example, as part of the transition to Fred Hutch there will be no changes to your doctor or care team. Over the longer term, this update to our structure will enable us to improve patients’ care experiences and increase integration across your care team.
Fred Hutch will focus on integrating teams and operations over the coming weeks and months but you will see some new changes coming soon.
During the transition and afterward, high-quality patient care, research and operations will continue uninterrupted. Seattle Children's, an original SCCA alliance partner, will work in close partnership with Fred Hutchinson Cancer Center to advance breakthroughs in adult and pediatric oncology.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
![]()
Learn more about UW Medicine
Learn more about our research at Fred Hutch